New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
13:58 EDTKOOLCesca Therapeutics partnership positive, says H.C. Wainwright
After Cesca (KOOL) announced an expanded collaboration with pan Asia-Pacific hospital owner Fortis Healthcare, H.C. Wainwright believes the announcement is "excellent news." The firm thinks the deal gives Cesca a stronger foothold in Asia and could enable its new cell therapy treatments to be approved more quickly. The firm views the stock as undervalued and keeps a $5 price target and Buy rating on the shares.
News For KOOL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
06:09 EDTKOOLCesca Therapeutics files IDE application for no-option critical limb ischemia
Cesca Therapeutics has submitted an investigational device exemption application to the FDA for a pivotal multicenter study of the company's SurgWerks-CLI and VXP System for treating advanced stages of no-option lower limb critical limb ischemia. The IDE application is the result of two prior positive pilot and feasibility studies conducted in Italy and India, respectively, and collaborative pre-IDE feedback from the U.S. FDA. The primary endpoint is major amputation free survival at 12 months following enrollment.
November 13, 2014
16:02 EDTKOOLCesca Therapeutics reports Q1 EPS (8c), consensus (7c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use